Skip to main content
. 2021 Oct 19;13(10):3665. doi: 10.3390/nu13103665

Table 1.

Descriptive statistics for the primary endpoint and the glycemic and insulin profiles measured at baseline (t0), after 30 days (t1), and after 60 days (t2) of BBR-PP supplementation.

Parameters t0 t1 t2
Value
Mean (SD)
Value
Mean (SD)
Variation vs. t0 (%) Value
Mean (SD)
Variation vs. t0 (%)
HOMA (pt) 2.86 (1.55) 1.81 (0.98) −36.7 1.47(0.63) −48.6 *
Glycemia (mg/dL) 85.08 (5.21) 79.33 (8.79) −6.8 76.08 (8.13) −10.6 **
Insulin (mcU/mL) 13.46 (7.25) 9.02 (4.31) −33.0 7.79 (3.11) −42.1 *

* p ≤ 0.005; ** p < 0.0005.